Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacoepidemiology Study on Real Life Impact of Chloroprocaine (CLOROTEKAL®) on the Eligibility for Discharge From Hospital of Patients Requiring Short Outpatient Surgery Under Spinal Anesthesia

NCT02152293 is registered in ClinicalTrials.gov with Nordic Pharma SAS as lead sponsor.

NCT NCT02152293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02152293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacoepidemiology Study on Real Life Impact of Chloroprocaine (CLOROTEKAL®) on the Eligibility for Discharge From Hospital of Patients Requiring Short Outpatient Surgery Under Spinal Anesthesia
Lead sponsor
Nordic Pharma SAS
Phase
Observational
Overall status
Completed
Start date
May 31, 2014
Completion date
January 31, 2015
Enrollment
620 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

outpatient surgery, spinal anesthesia